Tick-borne diseases in the United States: Rocky Mountain spotted fever and Colorado tick fever. A review.
The historical, clinical, ecological, and epidemiological features of Rocky Mountain spotted fever and Colorado tick fever, the two important tick-borne diseases in the United States, are reviewed. Rocky Mountain spotted fever, once considered a disease of the past, has again become a measurable public health problem. Its nationwide incidence has steadily increased since 1960 and has reached record proportions in 1976. The various factors responsible for this trend as well as for the mortality rates, which in spite of availability of effective antibiotics ranges from 5 to 10%, are discussed. Education of the public about ticks and their potential role as vectors of Rickettsia rickettsii and/or Colorado tick fever virus, and about the clinical manifestations of Rocky Mountain spotted fever, is considered the best means for preventing high incidence and mortality from these diseases.
D000914:Antibodies, Viral; D001733:Bites and Stings / Q000150:complications; D003121:Colorado Tick Fever / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology; D003122:Colorado tick fever virus / Q000302:isolation & purification / Q000502:physiology; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D008297:Male; D012088:Reoviridae Infections / Q000175:diagnosis*; D012284:Rickettsia rickettsii / Q000302:isolation & purification / Q000502:physiology; D012373:Rocky Mountain Spotted Fever / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology; D014481:United States
D000914:Antibodies, Viral